Relay Therapeutics
IPO
Transforming drug discovery
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- relaytx.com
- Total Funding
- $520.0M
- Last Round
- $400.0M Series CDec 2018
About
Relay Therapeutics is a clinical-stage precision medicines company that integrates leading-edge computational and experimental technologies through its proprietary Dynamo Platform. The platform models protein motion to identify and drug previously intractable targets. Its pipeline is focused on precision oncology and genetic disease, with multiple programs in clinical development including collaborations with major pharma partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account